Atlas Trials

Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn

Clinical trial NCT01789723 · WITHDRAWN

Trial details

NCT number
NCT01789723
Sponsor
Acrotech Biopharma Inc.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non Hodgkin's Lymphoma
Start date
2013-03-01
Primary completion
2015-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.